A system of wirelessly-controlled MEMS- based, patented microsensors for commercial devices targeting neuro and cardiovascular applications
Our sensing approach uses electrochemical impedance to transduce 5 key modalities simultaneously - flow rate, fluid pressure, obstruction level, temperature and pulse.
Microsensors track key modalities in real time and upload to a secure database to monitor therapeutic efficacy.
By collecting actionable data as changes occur, the sensors provide early diagnosis and the ability to predict serious health issues before they occur, decreasing hospital readmission rates and additional complications.
The sensors decrease false positive and false negative data output to ensure greater accuracy by detecting the 5 key modalities simultaneously.